SCHEMBL7071609

SCHEMBL7071609

Cc1nc(-c2ccc(CN3CCN(C(=O)c4ccc5ccccc5c4)CC3)cc2)no1

nearest known ligand 0.65

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.65
STAT3 P40763 9/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
TSHR P16473 4/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
HPGD P15428 1/20 0.50
ALDH1A1 P00352 2/20 0.49
MAPT P10636 2/20 0.49
MGLL Q99685 1/20 0.49
HTT P42858 1/20 0.49
MAPK14 Q16539 2/20 0.49
LMNA P02545 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
MAPK1 P28482 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
HSD17B10 Q99714 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7076687 0.90 TSHR (0.59) NPC1TSHRMEN1KMT2AHPGD
SCHEMBL7070548 0.89 MGLL (0.56) STAT3CYP2C9CYP2C19TSHRMEN1
SCHEMBL7074835 0.86 KMT2A (0.58) TSHRMEN1KMT2AALDH1A1MAPT
SCHEMBL7999739 0.86 NPC1 (0.47) NPC1STAT3TSHRHPGDMGLL
SCHEMBL7996195 0.80 NPC1 (0.42) NPC1TSHRMEN1KMT2AHPGD
SCHEMBL7074071 0.79 KDM4E (0.56) TSHRMEN1KMT2AALDH1A1MAPT
SCHEMBL7389702 0.79 MGLL (0.47) NPC1TSHRHPGDALDH1A1MAPT
SCHEMBL7074772 0.78 MGLL (0.66) TSHRMEN1KMT2AHPGDALDH1A1
SCHEMBL7075993 0.77 ATM (0.66) TSHRMEN1KMT2AALDH1A1MAPT
SCHEMBL7999722 0.77 ALDH1A1 (0.45) TSHRKMT2AALDH1A1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1025086-B1 BENZAMIDINE DERIVATIVES AS FACTOR XA INHIBITORS MERCK PATENT GMBH (DE) 2003-06-25 EP disclosed
US-6492368-B1 Benzamidine derivatives as factor XA inhibitors MERCK PATENT GMBH (DE) 2002-12-10 US disclosed